Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tim23B, formally known as mitochondrial import inner membrane translocase subunit Tim23B (TIMM23B), is a protein localized to the mitochondrial inner membrane and is predicted to participate in the translocation of transit peptide-containing precursor proteins across the inner membrane into the mitochondrial matrix[2][6][7]. It is believed to be a component of, or related to, the TIM23 complex, which functions in conjunction with other proteins to facilitate protein import into mitochondria, a process that is critical for mitochondrial biogenesis and function[1][3]. The gene TIMM23B is paralogous to TIMM23 and its exact physiological distinctions relative to the canonical Tim23 subunit remain incompletely characterized[2][6][7]. There is currently no evidence that TIMM23B serves as a direct therapeutic target, nor are there known drugs, disease associations, or biomarker roles described for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim23B (TIMM23B).